M A N Sendur1, S Aksoy, N Y Ozdemir, N Zengin. Show Affiliations » 1. Ankara Numune Education and Research Hospital, Department of Medical Oncology, Ankara, Turkey.
Abstract
Mesh： See more » Adenocarcinoma/drug therapyAdenocarcinoma/enzymologyAdenocarcinoma/secondaryAdenocarcinoma of LungAntineoplastic Agents/therapeutic useErbB Receptors/antagonists & inhibitorsErbB Receptors/metabolismErlotinib HydrochlorideFemaleHumansLung Neoplasms/drug therapyLung Neoplasms/enzymologyLung Neoplasms/pathologyMiddle AgedProtein Kinase Inhibitors/therapeutic useQuinazolines/therapeutic useSkin Neoplasms/secondaryTreatment Outcome
Substances： See more » Antineoplastic AgentsProtein Kinase InhibitorsQuinazolinesErlotinib HydrochlorideEGFR protein, humanErbB Receptors
Year: 2013 PMID： 23818376
Source DB: PubMed Journal: J BUON ISSN： 1107-0625 Impact factor: 2.533